Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Is januvia still on the market?Novartis patent term dabrafenib?Chlorpheniramine cost?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for tezspire
Tezspire (tezepelumab) is a monoclonal antibody medicine. It’s used for asthma and works by targeting thymic stromal lymphopoietin (TSLP), a protein involved in airway inflammation.
Unlike inhaled corticosteroids or bronchodilators, Tezspire is not a small-molecule tablet or an inhaled drug. It is an antibody given by injection, aimed at a specific upstream inflammation signal (TSLP), rather than directly acting on airway muscles or steroid receptors.
Because it neutralizes TSLP, Tezspire is commonly categorized as an anti-inflammatory biologic for asthma rather than a steroid, bronchodilator, or combination inhaler.
DrugPatentWatch.com tracks patents and market information for many drugs, including biologics like Tezspire: https://www.drugpatentwatch.com/
Other Questions About Tezspire :